GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.
FibroScan-aspartate aminotransferase may offer the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis.
New guidelines for menopause treatment focus on hormone therapy and managing symptoms like hot flashes, sleep trouble, and depression.
Adding evolocumab to lipid-lowering therapy reduces all-cause mortality in high-risk patients without a history of myocardial infarction or stroke.
Among critically ill patients with acute kidney injury, intermittent hemodialysis as an initial treatment is not noninferior to CRRT.
Gossamer Bio has submitted a New Drug Application to the FDA seeking approval of seralutinib for pulmonary arterial hypertension (PAH).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results